Home › To sell or not to sell: United Therapeutics faces choice with potential fast-track drug voucher
 

Keywords :   


To sell or not to sell: United Therapeutics faces choice with potential fast-track drug voucher

2015-03-18 21:42:25| Biotech - Topix.net

Martine Rothblatt is the CEO of United Therapeutics Corp., which recently received Food and Drug Administration approval for its drug, Unituxin for treating pediatric patients with high-risk neuroblastoma. It also received a voucher that can be used to fast track a drug through the FDA's regulatory process.

Tags: united sell potential choice

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Eastern North Pacific Tropical Weather Outlook
08.07Atlantic Tropical Weather Outlook
08.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Graphics
07.07Tropical Storm Beryl Forecast Discussion Number 37
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Wind Speed Probabilities Number 37
More »